MedTrace Logo

Electrolyte State in Patients With COVID-19

NCT04539834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 983

Last updated 2021-11-23

No results posted yet for this study

Summary

Initial case reports and cohort studies have described many clinical characteristics of patients with coronavirus disease 2019 (COVID-19), an emerging infectious disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In early COVID-19 studies, some evidence has been provided that electrolyte disorders may also be present upon patients' presentation, including sodium, potassium, chloride and calcium abnormalities

the aim of the study is Identification of elements that affect COVID-19 pathology to improve survival and decrease mortality rate.

Conditions

  • Electrolyte Imbalance

Interventions

OTHER

electrolytes

measuring level of electrolytes

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Tarek Hamdy, MD · lecturer of Chest diseases, Faculty of Medicine, Zagazig University

  • Hadeer El Shahaat, master degree · Assistant lecturer of Chest diseases, Faculty of Medicine, Zagazig University

  • Ahmed Abdulsaboor, MD · Clinical Pathology Department, Faculty of Medicine, Zagazig University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-08-01
Completion
2021-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04539834 on ClinicalTrials.gov